Skip Navigation Links
National Institutes of Health

Clinical Trials

Panic Disorder

Featured Studies

Featured studies include only those currently recruiting participants. They are listed according to the date they were added to the ClinicalTrials.gov registry, with the most recent studies appearing first.

  • CO2 Inhalation and Risk for Panic Disorder.
    Evaluation study. Objective: To examine respiratory/physiological and subjective responding as well as genetic transmission among offspring of parents with a history of or current panic disorder (PD) diagnosis to determine whether diagnoses/symptoms, endophenotypes, or genetic profiles in offspring is differentially related to parent PD subtypes (i.e., respiratory and non-respiratory panic). Ages 9-20. Locations in Bethesda, MD; Richmond, VA.
  • Evaluating the Effects of Stress in Pregnancy.
    Evaluation study. This study will evaluate pregnant women with a past or current diagnosis of depression or anxiety to gain a better understanding of how these disorders can affect an infant's development, both during and after pregnancy. Ages 18-45. Location in Atlanta, GA.
  • Genetic Causes of Panic Disorder.
    Evaluation study. This study will try to identify genes that increase the risk of developing panic disorder-an anxiety disorder characterized by recurrent unexpected panic attacks-and that contribute to the abnormalities associated with it. Ages 18-60. Location in Bethesda, MD.

Search ClinicalTrials.gov for other NIH studies on Panic Disorder.